🟢 Pyxis Oncology is trading 5.7% up today as biotech sector outperforms

Pyxis Oncology is trading 5.7% higher at $3.63, with biotech-sector strength providing the strongest available explanation for the move.

• Shares opened higher on September 2, 2026.
• The XBI is up 2.75%, while broader markets are only modestly higher.
• No clear company-specific catalyst was identified; the latest announcement involved upcoming investor conferences rather than material clinical, regulatory, or financial news. Confidence is medium given limited company-specific news flow.